Cardiac implantable electrical devices: Bioethics and management issues near the end of life

Ochsner Journal

Volumn 11, Issue 4, 2011, Pages 342-347

  Abi Samra, Freddy M ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Cardiac implantable electrical device; Defibrillator; End of life; Pacemaker

Indexed keywords

AMIODARONE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; BIOETHICS; BRADYCARDIA; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR EQUIPMENT; CASE REPORT; CLINICAL EFFECTIVENESS; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; DISEASE ASSOCIATION; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; ELECTRICAL EQUIPMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; ISCHEMIC CARDIOMYOPATHY; LARGE CELL LYMPHOMA; MALE; PROSTATE CANCER; QUALITY OF LIFE; SQUAMOUS CELL CARCINOMA; TERMINAL CARE; TONGUE CARCINOMA; TREATMENT FAILURE;

EID: 83755229112     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Terri Schiavo dies, battle continues-US News. May 31, 2005. http://www.msnbc.msn.com/id/7293186/. Accessed September 20, 2011.
2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996 Dec 26;335(26):1933-1940.
3. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 1999 Dec 16;341(25):1882-1890; Erratum in: N Engl J Med. 2000 Apr 27;342(17):1300.
4. Moss AJ, Zareba W, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877-883.
5. Greenberg H, Case RB, Moss AJ, Brown MW, Carroll ER, Andrews ML, MADIT-II Investigators. Analysis of mortality events in the Multicenter Automatic Defibrillator Implantation Trial (MADIT-II).J Am Coll Cardiol. 2004 Apr 21;43(8):1459-1465.
6. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004 May 20;350(21):2140-2150.
7. Daubert C, Gold MR, Abraham WT, et al. REVERSE Study Group. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009 Nov 10;54(20):1837-1846.
8. Moss AJ, Hall WJ, Cannom DS, et al. MADIT-CRT Trial Investigators. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009 Oct 1;361(14): 1329-1338.
9. Tang AS, Wells GA, Talajic M, et al. Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010 Dec 16;363(25):2385-2395.
10. Cleland JG, Daubert JC, Erdmann E, et al. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005 Apr 14;352(15):1539-1549.
11. Goldstein NE, Lampert R, Bradley E, Lynn J, Krumholz HM. Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004 Dec 7;141(11):835-838.
12. Kramer DB, Kesselheim AS, Brock DW, Maisel WH. Ethical and legal views of physicians regarding deactivation of cardiac implantable electrical devices: a quantitative assessment. Heart Rhythm. 2010 Nov;7(11):1537-1542.
13. Kramer DB, Kesselheim AS, Salberg L, Brock DW, Maisel WH. Ethical and legal views regarding deactivation of cardiac implantable electrical devices in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2011 Apr 1;107(7):1071. e5-1075.e5.
14. Lampert R, Hayes DL, Annas GJ, et al. American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine, American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010 Jul;7(7):1008-1026.
15. Padeletti L, Arnar DO, Boncinelli L, et al. Reviewers: Kirchhof P, Becker R, Cosio F, et al; European Heart Rhythm Association; Heart Rhythm Society. EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy. Europace. 2010 Oct;12(10):1480-1489; Erratum in: Europace. 2011 Apr;13(4):599.
16. Houmsse M, Franco V, Abraham WT. Epidemiology of sudden cardiac death in patients with heart failure. Heart Fail Clin. 2011 Apr;7(2):147-155, vii.
17. Bänsch D, Castrucci M, Böcker D, Breithardt G, Block M. Ventricular tachycardias above the initially programmed tachycardia detection interval in patients with implantable cardioverter-defibrillators: incidence, prediction and significance. J Am Coll Cardiol. 2000 Aug;36(2):557-565.
18. Bänsch D, Steffgen F, Grönefeld G, et al. The 1 + 1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias. Circulation. 2004 Aug 31;110(9):1022-1029.
19. Chia KKM, Di Biase L, Pieragnoli P, et al. ICD therapy-ATP. In: Ahmad AL, Ellenbogen KA, Natale A, Want PJ, eds. Pacemakers in Implantable Cardioverter Defibrillators: An Expert's Manual. Minneapolis, MN: Cardiotext Publishing; 2010:295-308.
20. Coman J, Freedman R, Koplan BA, et al. LIFE Study Results. A blended sensor restores chronotropic response more favorably than an accelerometer alone in pacemaker patients: the LIFE study results. Pacing Clin Electrophysiol. 2008 Nov;31(11): 1433-1442.
21. Lamas GA, Knight JD, Sweeney MO, et al. Impact of rate-modulated pacing on quality of life and exercise capacity- evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). Heart Rhythm. 2007 Sep;4(9):1125-1132.
22. Newman D, Lau C, Tang AS, et al. CTOPP Investigators. Effect of pacing mode on health-related quality of life in the Canadian Trial of Physiologic Pacing. Am Heart J. 2003 Mar;145(3):430-437.